Evidence map›Paper›PMID 24558349›Full record

ArticlePLoS biology2014

Pre-B cell receptor signaling induces immunoglobulin κ locus accessibility by functional redistribution of enhancer-mediated chromatin interactions.

Ralph Stadhouders, Marjolein J W de Bruijn, Magdalena B Rother, Saravanan Yuvaraj, Claudia Ribeiro de Almeida, Petros Kolovos, Menno C Van Zelm, Wilfred van Ijcken, Frank Grosveld, Eric Soler and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function.Advances in experimental medicine and biology · 2024
    Review
  3. Article
  4. The endogenousFrontiers in immunology · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. The Ig heavy chain protein but not its message controls early B cell development.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Genome Topology Control of Antigen Receptor Gene Assembly.Journal of immunology (Baltimore, Md. : 1950) · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Ralph StadhoudersDepartment of Cell Biology, Erasmus MC Rotterdam, The Netherlands.
Marjolein J W de BruijnDepartment of Pulmonary Medicine, Erasmus MC Rotterdam, The Netherlands.
Magdalena B RotherDepartment of Immunology, Erasmus MC Rotterdam, The Netherlands.
Saravanan YuvarajDepartment of Pulmonary Medicine, Erasmus MC Rotterdam, The Netherlands.
Claudia Ribeiro de AlmeidaDepartment of Pulmonary Medicine, Erasmus MC Rotterdam, The Netherlands.
Petros KolovosDepartment of Cell Biology, Erasmus MC Rotterdam, The Netherlands.
Menno C Van ZelmDepartment of Immunology, Erasmus MC Rotterdam, The Netherlands.
Wilfred van IjckenCenter for Biomics, Erasmus MC Rotterdam, The Netherlands.
Frank GrosveldDepartment of Cell Biology, Erasmus MC Rotterdam, The Netherlands ; The Cancer Genomics Center, Erasmus MC Rotterdam, The Netherlands.
Eric SolerDepartment of Cell Biology, Erasmus MC Rotterdam, The Netherlands ; The Cancer Genomics Center, Erasmus MC Rotterdam, The Netherlands ; INSERM UMR967 and French Alternative Energies and Atomic Energy Commission (CEA), Fontenay-aux-Roses, France.
Rudi W HendriksDepartment of Pulmonary Medicine, Erasmus MC Rotterdam, The Netherlands.
Erasmus MC · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During B cell development, the precursor B cell receptor (pre-BCR) checkpoint is thought to increase immunoglobulin κ light chain (Igκ) locus accessibility to the V(D)J recombinase. Accordingly, pre-B cells lacking the pre-BCR signaling molecules Btk or Slp65 showed reduced germline V(κ) transcription. To investigate whether pre-BCR signaling modulates V(κ) accessibility through enhancer-mediated Igκ locus topology, we performed chromosome conformation capture and sequencing analyses. These revealed that already in pro-B cells the κ enhancers robustly interact with the ∼3.2 Mb V(κ) region and its flanking sequences. Analyses in wild-type, Btk, and Slp65 single- and double-deficient pre-B cells demonstrated that pre-BCR signaling reduces interactions of both enhancers with Igκ locus flanking sequences and increases interactions of the 3'κ enhancer with V(κ) genes. Remarkably, pre-BCR signaling does not significantly affect interactions between the intronic enhancer and V(κ) genes, which are already robust in pro-B cells. Both enhancers interact most frequently with highly used V(κ) genes, which are often marked by transcription factor E2a. We conclude that the κ enhancers interact with the V(κ) region already in pro-B cells and that pre-BCR signaling induces accessibility through a functional redistribution of long-range chromatin interactions within the V(κ) region, whereby the two enhancers play distinct roles.

Indexed as

Enhancer Elements, GeneticAnimalsCells, CulturedChromatinChromatin Assembly and DisassemblyEpistasis, GeneticHistonesImmunoglobulin kappa-ChainsMiceMice, Inbred C57BLMice, TransgenicPrecursor Cells, B-LymphoidProtein Processing, Post-TranslationalReceptors, Antigen, B-CellSignal TransductionTranscriptomeChromatinHistonesImmunoglobulin kappa-ChainsReceptors, Antigen, B-Cell

Identifiers

PMID24558349
PMCPMC3928034
OpenAlexW2052107075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.